Farmacología, Farmacognosia y Botánica
Departamento
Instituto de Investigación Sanitaria Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (21)
2023
-
Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors
European Journal of Hospital Pharmacy
-
Interaction between maternal immune activation and peripubertal stress in rats: impact on cocaine addiction-like behaviour, morphofunctional brain parameters and striatal transcriptome
Translational Psychiatry, Vol. 13, Núm. 1
-
The long-term effects of adolescent Δ9-tetrahydrocannabinol on brain structure and function assessed through neuroimaging techniques in male and female rats
European Neuropsychopharmacology, Vol. 74, pp. 47-63
2021
-
Error detection and cost savings with an image-based workflow management system connected to a computerized prescription order entry program for antineoplastic compounding
Journal of Patient Safety, Vol. 17, Núm. 8, pp. E1589-E1594
2020
-
Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents
American Journal of Health-System Pharmacy, Vol. 77, Núm. 17, pp. 1393-1402
-
Polypharmacy and drug-drug interactions in people living with human immunodeficiency virus in the region of Madrid, Spain: A population-based study
Clinical Infectious Diseases, Vol. 71, Núm. 2, pp. 353-362
2019
-
Development and Evaluation of a Clinical Decision Support System to Improve Medication Safety
Applied Clinical Informatics, Vol. 10, Núm. 3, pp. 513-520
-
Drug cost avoidance in clinical trials of breast cancer
Journal of Oncology Pharmacy Practice, Vol. 25, Núm. 5, pp. 1099-1104
-
Robotic dispensing improves patient safety, inventory management, and staff satisfaction in an outpatient hospital pharmacy
Journal of Evaluation in Clinical Practice, Vol. 25, Núm. 1, pp. 28-35
2018
-
Drug cost avoidance resulting from breast cancer clinical trials
European Journal of Clinical Pharmacy, Vol. 20, Núm. 1, pp. 6-10
-
Estudio comparativo de contaminación de tres sistemas cerrados para la preparación de fármacos peligrosos mediante simulación con fluoresceína
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 42, Núm. 6, pp. 234-238
-
Failure mode and effects analysis to improve quality in clinical trials
Journal of Healthcare Quality Research, Vol. 33, Núm. 1, pp. 33-47
-
MouBeAT: A new and open toolbox for guided analysis of behavioral tests in mice
Frontiers in Behavioral Neuroscience, Vol. 12
-
Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study
Expert Opinion on Drug Safety, Vol. 17, Núm. 3, pp. 235-241
2017
-
Identification of new SNPs associated with severe toxicity to capecitabine
Pharmacological Research, Vol. 120, pp. 133-137
-
Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project
International Journal of Clinical Practice, Vol. 71, Núm. 8
-
Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicity
Pharmacogenomics, Vol. 18, Núm. 13, pp. 1215-1223
2016
-
Cell expansion-dependent inflammatory and metabolic profile of human bone marrow mesenchymal stem cells
Frontiers in Physiology, Vol. 7, Núm. NOV
-
Guiding pharmacist clinical interviews: A safety tool to support the education of patients treated with oral antineoplastic agents
Expert Opinion on Drug Safety, Vol. 15, Núm. 4, pp. 427-435
-
Optimisation of antithrombotic therapy in patients with acute coronary syndrome to reduce bleeding episodes
International Journal of Clinical Practice, Vol. 70, Núm. 2, pp. 156-162